New combo trial aims to tame tough breast cancers

NCT ID NCT05846789

Summary

This study is testing if adding the drug tocilizumab to standard chemotherapy works better than chemotherapy alone for controlling metastatic triple-negative or estrogen-receptor-low breast cancer. It will enroll 168 Black and non-Black patients to see if the combination improves tumor response and delays cancer growth. The trial also aims to understand if treatment effects differ between racial groups.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University

    RECRUITING

    Durham, North Carolina, 27708, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • IU Health Joe and Shelly Schwarz Cancer Center

    RECRUITING

    Carmel, Indiana, 46032, United States

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    RECRUITING

    Indianapolis, Indiana, 46202, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Roswell Park Comprehensive Cancer Center

    RECRUITING

    Buffalo, New York, 14203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Sidney and Lois Eskenazi Hospital

    RECRUITING

    Indianapolis, Indiana, 46202, United States

Conditions

Explore the condition pages connected to this study.